| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD22-directed Immunoconjugate [EPC] | 1 | 0.0003 |
| 1 | Topoisomerase Inhibitor [EPC] | 11 | 0.0001 |
| 2 | Platinum-based Drug [EPC] | 25 | 0.0001 |
| 3 | Microtubule Inhibitor [EPC] | 9 | 0.0001 |
| 4 | Programmed Death Ligand-1 Blocker [EPC] | 1 | 0.0000 |
| 5 | Androgen Receptor Inhibitor [EPC] | 3 | 0.0000 |
| 6 | Nucleoside Metabolic Inhibitor [EPC] | 11 | 0.0000 |
| 7 | Radiographic Contrast Agent [EPC] | 1 | 0.0000 |
| 8 | Alkylating Drug [EPC] | 9 | 0.0000 |
| 9 | BCL-2 Inhibitor [EPC] | 1 | 0.0000 |
| 10 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 2 | 0.0000 |
| 11 | Estrogen [EPC] | 2 | 0.0000 |
| 12 | Leukocyte Growth Factor [EPC] | 1 | 0.0000 |
| 13 | Kinase Inhibitor [EPC] | 2 | 0.0000 |
| 14 | CD20-directed Cytolytic Antibody [EPC] | 1 | 0.0000 |
| 15 | Folate Analog Metabolic Inhibitor [EPC] | 1 | 0.0000 |
| 16 | Corticosteroid [EPC] | 1 | 0.0000 |